Why the study?
Ecological neuroimaging using multimodal EEG-fNIRS during clinical tests may support early Alzheimer's disease diagnosis by measuring brain activity and neurovascular coupling modifications.
Can complexity analysis of multimodal EEG-fNIRS detect working memory decline and classify early Alzheimer's disease patients versus healthy controls?
Can complexity analysis of multimodal EEG-fNIRS detect working memory decline and classify early Alzheimer's disease patients versus healthy controls?
Complexity analysis of multimodal EEG-fNIRS during working memory tasks can effectively distinguish early Alzheimer's disease patients from healthy controls.
Supports exploration of entropy-based multimodal EEG-fNIRS for early AD classification; hypothesis-generating, requires prospective validation before clinical use.
Alzheimer's disease (AD) is characterized by working memory (WM) failures that can be assessed at early stages through administering clinical tests. Ecological neuroimaging, such as Electroencephalography (EEG) and functional Near Infrared Spectroscopy (fNIRS), may be employed during these tests to support AD early diagnosis within clinical settings. Multimodal EEG-fNIRS could measure brain activity along with neurovascular coupling (NC) and detect their modifications associated with AD. Data analysis procedures based on signal complexity are suitable to estimate electrical and hemodynamic brain activity or their mutual information (NC) during non-structured experimental paradigms. In this study, sample entropy of whole-head EEG and frontal/prefrontal cortex fNIRS was evaluated to assess brain activity in early AD and healthy controls (HC) during WM tasks (i.e., Rey-Osterrieth complex figure and Raven's progressive matrices). Moreover, conditional entropy between EEG and fNIRS was evaluated as indicative of NC. The findings demonstrated the capability of complexity analysis of multimodal EEG-fNIRS to detect WM decline in AD. Furthermore, a multivariate data-driven analysis, performed on these entropy metrics and based on the General Linear Model, allowed classifying AD and HC with an AUC up to 0.88. EEG-fNIRS may represent a powerful tool for the clinical evaluation of WM decline in early AD.
No takes yet. Share an insight, caveat, or question.
Perpetuini et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: